The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC).
 
Kim van der Zande
No Relationships to Disclose
 
Vincent van der Noort
No Relationships to Disclose
 
Milou Busard
No Relationships to Disclose
 
Paul Hamberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BMS Brazil; Ipsen; MSD; Pfizer
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Suzan Ras - van Spijk
No Relationships to Disclose
 
Jeantine De Feijter
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Pfizer
 
Vincent O. Dezentjé
Consulting or Advisory Role - Daiichi Sankyo
 
Metin Tascilar
No Relationships to Disclose
 
Danny Houtsma
Consulting or Advisory Role - Amgen; Astellas Pharma; Pfizer
 
Aart Beeker
No Relationships to Disclose
 
H Pieter van den Berg
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Janssen
Speakers' Bureau - Janssen
 
Diederik ten Oever
No Relationships to Disclose
 
Irma M. Oving
No Relationships to Disclose
 
Wilbert Zwart
Honoraria - astellas pharma
Speakers' Bureau - Astellas Pharma
Research Funding - Astellas Pharma
 
Andre M. Bergman
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)